Gå offline med appen Player FM !
Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301
Manage episode 331831142 series 2812899
Welcome to our podcast episode on the treatment of urothelial carcinoma. In this episode, hosted by Anna Christofides, we discuss updated results of the Phase 3 EV-301 trial, presented at ASCO 2022, that examined the efficacy and safety of Enfortumab Vedotin, or EV, versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma.
Our Guest:
Our guest for this episode is Dr Nimira Alimohamed, Medical Oncologist and Clinical Associate Professor of Medicine at the University of Calgary and Medical Oncologist at the Tom Baker Cancer Centre in Calgary, Alberta.
This podcast episode was sponsored by Seagen Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 episoder
Manage episode 331831142 series 2812899
Welcome to our podcast episode on the treatment of urothelial carcinoma. In this episode, hosted by Anna Christofides, we discuss updated results of the Phase 3 EV-301 trial, presented at ASCO 2022, that examined the efficacy and safety of Enfortumab Vedotin, or EV, versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma.
Our Guest:
Our guest for this episode is Dr Nimira Alimohamed, Medical Oncologist and Clinical Associate Professor of Medicine at the University of Calgary and Medical Oncologist at the Tom Baker Cancer Centre in Calgary, Alberta.
This podcast episode was sponsored by Seagen Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 episoder
모든 에피소드
×![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 17:37
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Highlights from EHA 2024 - Updates on the Treatment of CLL 42:13
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL 16:33
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Cutting Edge Advances in the Treatment of Lung Cancer 15:13
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers 41:28
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Immunotherapy for Kidney Transplant Patients with Skin Cancer 21:32
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective 24:11
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM 16:58
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL 13:48
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC 32:28
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion 26:41
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion 8:07
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment 14:52
![IMPACT Medicom podcast artwork](/static/images/64pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs 10:38
Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.